Fundraising Fox
Orbis Medicines
48 employees on LinkedIn · 6 known investors
Find your way into Orbis Medicines
Sign up to see every warm intro you have to Orbis Medicines
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Orbis Medicines team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Orbis Medicines is a drug discovery company developing orally bioavailable macrocycle drug candidates as alternatives to injectable biologics, targeting both intracellular and extracellular protein targets. It uses a proprietary chemistry and machine-learning platform to systematically explore macrocycle chemical space and generate optimized drug candidates.
Investors · 6
How we know: a partner's Signal profile · funding news · biopharmadive.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · biopharmadive.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · biopharmadive.com · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AJan 2025 · 2 sources
NEA (lead), Cormorant Asset Management, Export and Investment Fund of Denmark, Forbion, Lilly Ventures, Novo Holdings
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Roundup: Orbis Enters $1.4 Billion Partnership with Novo, Dualitas Therapeutics Enters Research collaboration with Roche, Aethlon Medical Merges with North Immunology | PharmExecpharmexec.com · Sep 2026
Orbis Medicines Enters Multi-Target Drug Discovery Partnership with Novo Nordisk Worth up to USD 1.4 Billion - BioSpacebiospace.com · Sep 2026Frequently asked questions
- What does Orbis Medicines do?
- Orbis Medicines is a drug discovery company developing orally bioavailable macrocycle drug candidates as alternatives to injectable biologics, targeting both intracellular and extracellular protein targets. It uses a proprietary chemistry and machine-learning platform to systematically explore macrocycle chemical space and generate optimized drug candidates.
- Who are Orbis Medicines's investors?
- Orbis Medicines's investors include New Enterprise Associates (NEA), Forbion, Lilly Ventures, Novo Holdings.